CompletedNot applicableNCT01472874
Single Daily Dosage of Trientine for Maintenance Treatment for Wilson Disease
Studying Wilson disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Yale University
- Principal Investigator
- Michael Schilsky, MDYale University
- Intervention
- Once a day Trientine(drug)
- Enrollment
- 8 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2010 – 2011
Study locations (1)
- Yale University, New Haven, Connecticut, United States
Collaborators
Bausch Health Americas, Inc.
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01472874 on ClinicalTrials.govOther trials for Wilson disease
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07301216Off Treatment Urinary Copper Excretion in Wilson Disease, Pilot StudyYale University
- RECRUITINGEARLY PHASE1NCT07240896A Clinical Study on the Treatment of Wilson Disease With ATP7B mRNA/LNP (DSL101)DSciLab Co., Ltd.
- RECRUITINGNCT07226622Prescreening Study to Identify Potential Wilson Disease Participants for Gene-Editing Clinical TrialPrime Medicine, Inc.
- RECRUITINGNANCT06945081Wilson's Disease Treated With D-Penicillamine: Characterization of Skin Damage Secondary to Treatment by Measuring Skin ElasticityCentre Hospitalier Universitaire de Saint Etienne
- ENROLLING BY INVITATIONNCT07159581Gene Therapy for Wilson Disease Evaluated by 64Cu PET/CTThomas Damgaard Sandahl
- RECRUITINGNCT06430359Circadian Variation of Urinary Copper Excretion in Wilson Disease PatientsHospices Civils de Lyon
- RECRUITINGEARLY PHASE1NCT06650319A Clinical Study to Evaluate the Safety and Efficacy of LY-M003 Injection in Patients With Wilson DiseaseChaohui Yu
- RECRUITINGNCT05444127Oral Health and Wilson's Disease: SOMAWIFondation Ophtalmologique Adolphe de Rothschild